ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

Shubick Blasts Tobacco Industry Scientists

October 4, 1974

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984

In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center

December 2, 1994

Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer

November 26, 2010

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Leukemia Society Program In Transitional Research.

January 14, 2000